The overarching goal of our research program is to develop novel analytical and computational tools to aid in clinical decision making for precision oncology. Specifically, we focus on the discovery of imaging and molecularly-based biomarkers for predicting patient survival and response to cancer therapy. Other areas of our research include MRI-based radiation treatment planning and image-guided radiation therapy.